469
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Diet and lifestyle interventions on lipids: combination with genomics and metabolomics

&
Pages 417-427 | Published online: 18 Jan 2017

References

  • Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102(10), 1082–1085 (2000).
  • Lamarche B, Tchernof A, Moorjani S et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95(1), 69–75 (1997).
  • Van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 60(8), 1094–1102 (2011).
  • Greenhill C. Cancer: HDL cholesterol and cancer risk. Nat. Rev. Gastroenterol. Hepatol. 8(6), 299 (2011).
  • Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM. Lipoprotein(a) and risk of Type 2 diabetes. Clin. Chem. 56(8), 1252–1260 (2010).
  • Wolk A, Furuheim M, Vessby B. Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J. Nutr. 131(3), 828–833 (2001).
  • Zheng Y, Yu B, Alexander D, Steffen LM, Boerwinkle E. Human Metabolome Associates with Dietary Intake Habits among African Americans in the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 179(12), 1424–1433 (2014).
  • Chorell E, Svensson MB, Moritz T, Antti H. Physical fitness level is reflected by alterations in the human plasma metabolome. Mol. Biosyst. 8(4), 1187–1196 (2012).
  • Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010). •• A large-scale genome-wide association study revealed 95 loci contributing to the interindividual variation in lipid profile.
  • Global Lipids Genetics C, Willer CJ, Schmidt EM et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45(11), 1274–1283 (2013). •• A later genome-wide association study revealed further 62 loci influencing the circulating lipid metabolism.
  • Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134(6), 933–944 (2008).
  • Smilowitz JT, Zivkovic AM, Wan YJ et al. Nutritional lipidomics: molecular metabolism, analytics, and diagnostics. Mol. Nutr. Food Res. 57(8), 1319–1335 (2013).
  • Qi L. Gene–Diet interactions in complex disease: current findings and relevance for public health. Curr. Nutr. Rep. 1(4), 222–227 (2012).
  • CDC. NCHS Data Brief (2014). www.cdc.gov/nchs/data/databriefs/db92.htm
  • Parks EJ. Effect of dietary carbohydrate on triglyceride metabolism in humans. J. Nutr. 131(10), S2772–S2774 (2001).
  • Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77(5), 1146–1155 (2003).
  • Aucott L, Gray D, Rothnie H, Thapa M, Waweru C. Effects of lifestyle interventions and long-term weight loss on lipid outcomes - a systematic review. Obes. Rev. 12(5), e412–e425 (2011). • Recent systematic review summarizing the studies of diet and lifestyle modifications on lipid profile in adults.
  • Ho M, Garnett SP, Baur L et al. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis. Pediatrics 130(6), e1647–e1671 (2012). • Recent systematic review summarizing the studies of diet and lifestyle modifications on lipid profile in kids.
  • De Lorgeril M, Salen P, Monjaud I, Delaye J. The ‘diet heart’ hypothesis in secondary prevention of coronary heart disease. Eur. Heart J. 18(1), 13–18 (1997).
  • De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99(6), 779–785 (1999).
  • Burr ML, Fehily AM, Gilbert JF et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2(8666), 757–761 (1989).
  • Pirruccello J, Kathiresan S. Genetics of lipid disorders. Curr. Opin. Cardiol. 25(3), 238–242 (2010).
  • Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat. Rev. Genet. 10(2), 109–121 (2009).
  • Breslow JL. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu. Rev. Genet. 34, 233–254 (2000).
  • Hunter DJ, Altshuler D, Rader DJ. From Darwin’s finches to canaries in the coal mine--mining the genome for new biology. N. Engl. J. Med. 358(26), 2760–2763 (2008).
  • Sandhu MS, Waterworth DM, Debenham SL et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 371(9611), 483–491 (2008).
  • Krauss RM. What can the genome tell us about LDL cholesterol? Lancet 371(9611), 450–452 (2008).
  • Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. N. Engl. J. Med. 358(26), 2796–2803 (2008).
  • Lusis AJ, Pajukanta P. A treasure trove for lipoprotein biology. Nat. Genet. 40(2), 129–130 (2008).
  • Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF et al. Genome-wide association analysis identifies loci for Type 2 diabetes and triglyceride levels. Science316(5829), 1331–1336 (2007).
  • Kathiresan S, Melander O, Guiducci C et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40(2), 189–197 (2008).
  • Kathiresan S, Willer CJ, Peloso GM et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41(1), 56–65 (2009).
  • Morrison AC, Voorman A, Johnson AD et al. Whole-genome sequence-based analysis of high-density lipoprotein cholesterol. Nat. Genet. 45(8), 899–901 (2013).
  • Qi Q, Chu AY, Kang JH et al. Sugar-sweetened beverages and genetic risk of obesity. N. Engl. J. Med. 367(15), 1387–1396 (2012).
  • Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. Am. J. Clin. Nutr. 96(4), 917–922 (2012). • Significant interactions were identified between APOA5 variant and dietary fat in determining circulating lipid profile from a large and long-term trial.
  • Qi Q, Chu AY, Kang JH et al. Fried food consumption, genetic risk, and body mass index: gene–diet interaction analysis in three US cohort studies. BMJ 348, g1610 (2014).
  • Ordovas JM. Gene-diet interaction and plasma lipid response to dietary intervention. Curr. Atheroscler. Rep. 3(3), 200–208 (2001).
  • Lu Y, Feskens EJ, Dolle ME et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study. Am. J. Clin. Nutr. 92(1), 258–265 (2010).
  • Hellstrand S, Sonestedt E, Ericson U et al. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C. J. Lipid Res. 53(6), 1183–1189 (2012).
  • Kim DS, Burt AA, Ranchalis JE et al. Novel gene-byenvironment interactions: APOB and NPC1L1 variants affect the relationship 2between dietary and total plasma cholesterol. J. Lipid Res. 54(5), 1512–1520 (2013).
  • Liu WY, Yin RX, Zhang L et al. Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels. Alcohol 45(7), 681–687 (2011).
  • Yin RX, Li YY, Wu JZ et al. Interactions between the apolipoprotein a1/c3/a5 haplotypes and alcohol consumption on serum lipid levels. Alcohol Clin. Exp. Res. 37(2), 234–243 (2013).
  • Ruixing Y, Yiyang L, Meng L et al. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels. Lipids Health Dis.9, 86 (2010).
  • Corella D, Portoles O, Arriola L et al. Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort. J. Nutr. Biochem. 22(5), 487–494 (2011).
  • Garcia-Rios A, Perez-Martinez P, Fuentes F et al. Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia. Atherosclerosis210(2), 486–492 (2010).
  • Pollin TI, Isakova T, Jablonski KA et al. Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program. PLoS Genet. 8(8), e1002895 (2012). • Significant interaction was identified between a genetic risk score from 32 lipid-related variants and lifestyle intervention on LDL-cholesterol.
  • Brahe LK, Angquist L, Larsen LH et al. Influence of SNPs in nutrient-sensitive candidate genes and gene-diet interactions on blood lipids: the DiOGenes study. Br. J. Nutr. 110(5), 790–796 (2013). • Significant interaction was identified between LPIN1 variant and dietary protein on triglyceride concentration.
  • Corella D, Carrasco P, Sorli JV et al. Mediterranean diet reduces the adverse effect of the TCF7L2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence: a randomized controlled trial in a high-cardiovascular-risk population. Diabetes Care 36(11), 3803–3811 (2013). Variant and mediterranean diet on circulating lipid profile.
  • Ordovas JM, Tai ES. Why study gene-environment interactions? Curr. Opin. Lipidol 19(2), 158–167 (2008).
  • Sacks FM, Bray GA, Carey VJ et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 360(9), 859–873 (2009).
  • The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of Type 2 diabetes. Diabetes Care 22(4), 623–634 (1999).
  • Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002).
  • Larsen TM, Dalskov S, Van Baak M et al. The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries – a comprehensive design for long-term intervention. Obes. Rev. 11(1), 76–91 (2010).
  • Junyent M, Tucker KL, Smith CE et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J. Lipid Res. 50(3), 565–573 (2009).
  • Junyent M, Arnett DK, Tsai MY et al. Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women. J. Nutr. 139(5), 842–848 (2009).
  • Smith CE, Arnett DK, Tsai MY et al. Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. Atherosclerosis 206(2), 500–504 (2009).
  • Mattei J, Demissie S, Tucker KL, Ordovas JM. Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J. Nutr. 139(12), 2301–2308 (2009).
  • Garcia-Rios A, Perez-Martinez P, Mata P et al. Polymorphism at the TRIB1 gene modulates plasma lipid levels: insight from the Spanish familial hypercholesterolemia cohort study. Nutr. Metab. Cardiovasc. Dis. 21(12), 957–963 (2011).
  • Walker CG, Loos RJ, Olson AD et al. Genetic predisposition influences plasma lipids of participants on habitual diet, but not the response to reductions in dietary intake of saturated fatty acids. Atherosclerosis 215(2), 421–427 (2011).
  • Lockyer S, Tzanetou M, Carvalho-Wells AL, Jackson KG, Minihane AM, Lovegrove JA. SATgenepsilon dietary model to implement diets of differing fat composition in prospectively genotyped groups (apoE) using commercially available foods. Br. J. Nutr. 108(9), 1705–1713 (2012).
  • Armah CN, Traka MH, Dainty JR et al. A diet rich in highglucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function. Am. J. Clin. Nutr. 98(3), 712–722 (2013).
  • Lewis GD, Asnani A, Gerszten RE. Application of metabolomics to cardiovascular biomarker and pathway discovery. J. Am. Coll. Cardiol. 52(2), 117–123 (2008).
  • Quehenberger O, Dennis EA. The human plasma lipidome. N. Engl. J Med. 365(19), 1812–1823 (2011).
  • Shevchenko A, Simons K. Lipidomics: coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 11(8), 593–598 (2010).
  • Quehenberger O, Armando AM, Brown AH et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51(11), 3299–3305 (2010).
  • Meikle PJ, Christopher MJ. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr. Opin. Lipidol 22(3), 210–215 (2011).
  • Sorensen CM, Ding J, Zhang Q et al. Perturbations in the lipid profile of individuals with newly diagnosed Type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subset. Clin. Biochem. 43(12), 948–956 (2010).
  • Barber MN, Risis S, Yang C et al. Plasma lysophosphatidylcholine levels are reduced in obesity and Type 2 diabetes. PLoS ONE 7(7), e41456 (2012).
  • Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS ONE 4(7), e6261 (2009).
  • Hu C, Kong H, Qu F et al. Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy. Mol. Biosyst. 7(12), 3271–3279 (2011).
  • Kulkarni H, Meikle PJ, Mamtani M et al. Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols. Hypertension 62(3), 621–626 (2013).
  • Kien CL, Bunn JY, Poynter ME et al. A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults. Diabetes 62(4), 1054–1063 (2013).
  • Rhee EP, Cheng S, Larson MG et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Invest. 121(4), 1402–1411 (2011).
  • Qi L. Gene-diet interaction and weight loss. Curr. Opin‥ Lipidol. 25(1), 27–34 (2014).
  • Perez-Cornago A, Brennan L, Ibero-Baraibar I et al. Metabolomics identifies changes in fatty acid and amino acid profiles in serum of overweight older adults following a weight loss intervention. J. Physiol. Biochem. 70(2), 593–602 (2014).
  • Ubhi BK, Cheng KK, Dong J et al. Targeted metabolomics identifies perturbations in amino acid metabolism that subclassify patients with COPD. Mol. Biosyst. 8(12), 3125–3133 (2012).
  • Kobayashi T, Yoshida T, Fujisawa T et al. A metabolomicsbased approach for predicting stages of chronic kidney disease. Biochem. Biophys. Res. Comm. 445(2), 412–416 (2014).
  • Wang TJ, Larson MG, Vasan RS et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17(4), 448–453 (2011).
  • Shah SH, Bain JR, Muehlbauer MJ et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ. Cardiovasc. Genet. 3(2), 207–214 (2010).
  • Shah SH, Crosslin DR, Haynes CS et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 55(2), 321–330 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.